186 related articles for article (PubMed ID: 20579964)
1. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever.
Berkenstadt M; Weisz B; Cuckle H; Di-Castro M; Guetta E; Barkai G
Am J Obstet Gynecol; 2005 Oct; 193(4):1513-6. PubMed ID: 16202748
[TBL] [Abstract][Full Text] [Related]
3. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
7. [Colchicine in the first trimester of pregnancy and vertebral malformations].
Dudin A; Rambaud-Cousson A; Shehatto M; Thalji A
Arch Fr Pediatr; 1989 Oct; 46(8):627-8. PubMed ID: 2604518
[No Abstract] [Full Text] [Related]
8. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study.
Diav-Citrin O; Blyakhman S; Shechtman S; Ornoy A
Reprod Toxicol; 2013 Aug; 39():58-62. PubMed ID: 23602891
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.
Diav-Citrin O; Shechtman S; Tahover E; Finkel-Pekarsky V; Arnon J; Kennedy D; Erebara A; Einarson A; Ornoy A
Am J Psychiatry; 2014 Jul; 171(7):785-94. PubMed ID: 24781368
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome following in utero exposure to bisphosphonates.
Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
[TBL] [Abstract][Full Text] [Related]
16. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery.
Ofir D; Levy A; Wiznitzer A; Mazor M; Sheiner E
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):115-8. PubMed ID: 18771840
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?
Ben-Chetrit E; Ben-Chetrit A; Berkun Y; Ben-Chetrit E
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):143-8. PubMed ID: 20191511
[TBL] [Abstract][Full Text] [Related]
18. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling.
Brambati B; Tului L; Camurri L; Guercilena S
Am J Obstet Gynecol; 2004 Dec; 191(6):2035-40. PubMed ID: 15592288
[TBL] [Abstract][Full Text] [Related]
19. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
